Clinical Trial

Universal Genetic Testing for Cancer Risk Reduction

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this research study is to see if offering genetic testing for cancer-related genes is feasible and acceptable for patients presenting for gynecology clinic visits, instead of needing to see specialized providers or needing to meet specific criteria. The primary aim to assess the proportion of patients who undergo genetic testing, and the proportion of patients with pathogenic variants.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-11.
Trial Details
NCT Number NCT06926816
Lead Sponsor NYU Langone Health
Conditions Genetic Testing
Enrollment 600 participants
Start Date 2025-03-04
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-02